Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Nov;61(11):1000-8.
doi: 10.1136/thx.2005.052373.

Lung cancer in HIV infected patients: facts, questions and challenges

J Cadranel  1 , D Garfield, A Lavolé, M Wislez, B Milleron, C Mayaud
Affiliations
Review

Lung cancer in HIV infected patients: facts, questions and challenges

J Cadranel et al. Thorax. 2006 Nov.

Abstract

AIDS related mortality has fallen sharply in industrialised countries since 1996 following the introduction of highly active antiretroviral therapy. This has been accompanied by an increase in the proportion of deaths attributable to non-AIDS defining solid tumours, especially lung cancer. The risk of developing lung cancer seems to be higher in HIV infected subjects than in the general population of the same age, partly because the former tend more frequently to be smokers and, especially, intravenous drug users. The carcinogenic role of the antiretroviral nucleoside drugs and their interaction with smoking needs to be examined. Interestingly, there is no clear relationship between the degree of immunosuppression and the risk of lung cancer, so the reason for the increased risk is unknown. The mean age of HIV infected patients at the time of lung cancer diagnosis is 45 years and most are symptomatic. Lung cancer is diagnosed when locally advanced or metastatic (stage III-IV) in 75-90% of cases, similar to patients with unknown HIV status. Adenocarcinoma is the most frequent histological type. The prognosis is worse in HIV infected patients than in the general lung cancer population. Efficacy and toxicity data for chemotherapy and radiation therapy are few and imprecise. Surgery remains the treatment of choice for localised disease in patients with adequate pulmonary function and general good health, regardless of immune status. Prospective clinical trials are needed to define the optimal detection and treatment strategies for lung cancer in HIV infected patients.

PubMed Disclaimer

Conflict of interest statement

Competing interests: none declared.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Irwin L E, Begandy M K, Moore T M. Adenosquamous carcinoma of the lung and the acquired immunodeficiency syndrome. Ann Intern Med 1984100158 - PubMed
    1. Monfardini S, Vaccher E, Pizzocaro G.et al Unusual malignant tumours in 49 patients with HIV infection. AIDS 19893449–452. - PubMed
    1. Braun M A, Killam D A, Remick S C.et al Lung cancer in patients seropositive for human immunodeficiency virus. Radiology 1990175341–343. - PubMed
    1. Tirelli U, Spina M, Sandri S.et al Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors. Cancer 200088563–569. - PubMed
    1. Vyzula R, Remick S C. Lung cancer in patients with HIV‐infection. Lung Cancer 199615325–339. - PubMed